Patients underwent blood sampling to determine the area under the concentration-time curve ( AUC ) for carbamazepine and metabolite carbamazepine-10 ,11 - epoxide following oral ( day 0 ) and intravenous carbamazepine administration ( days 1 , 7 , and 8 ) .